Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia

Journal of Internal Medicine

Volumn 251, Issue 1, 2002, Pages 77-85

  Sebestjen M ^a   Zegura B ^a   Keber, I ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Arterial vasoreactivity; Cerivastatin; Combined hyperlipidaemia; Fenobibrate

Indexed keywords

CERIVASTATIN; FENOFIBRATE; GLYCERYL TRINITRATE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RISK FACTOR; ULTRASOUND;

ADULT; ANTILIPEMIC AGENTS; BRACHIAL ARTERY; DOUBLE-BLIND METHOD; HEMODYNAMIC PROCESSES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PROCETOFEN; PROSPECTIVE STUDIES; PYRIDINES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VASODILATION;

EID: 0036194213     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00928.x     Document Type: Article

References (33)

1. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
2. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms
3. Endothelial dysfunction: Does it matter? Is it reversible?
4. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol
5. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level
6. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta
7. Endothelial dysfunction in men with small LDL particles
8. Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans
9. Impaired brachial artery endothelial function is not predicted by elevated triglycerides
10. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
11. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men
12. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
13. Simvastatin, an HMG-coenzyme A reductase inhibitor improves endothelial function within 1 month
14. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate
15. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus
16. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
17. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
18. Hypertrigliceridemia, atherogenic dyslipidemia, and the metabolic syndrome
19. Evidence based approach for the management of mixed hyperlipidaemia
20. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge
21. International federation of clinical chemistry standardization project for measurements of apolipoproteins A1 and B
22. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
23. Lp (a) levels in healthy population measured by a new enzyme linked immunosorbent assay
24. A radioimmunoassay for the determination of insulins from several animal species, insulin derivatives and insulin precursors in both their native and denatured state
25. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
26. Longterm cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function
27. Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks
28. Inhibition of cyclic AMP- and cyclic GMP-mediated dilations in isolated arteries by oxidized low density lipoproteins
29. Cerivastatin in the treatment of mixed hyperlipidaemia: The RIGHT study
30. Clinical effficacy of cerivastatin: Phase IIa dose-ranging and dose-scheduling studies
31. Effect of fibric acid derivates on blood lipid and lipoprotein levels
32. Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia
33. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle aged men: Lower levels of oxidized LDL with statin therapy